Payment overview · 2025
General Payments
$253.48
13 reported records · 9 companies
Healthcare provider profile · identity verified
Khaja Asadullah, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · FRANKFORT, IL · NPI 1578515409
Verified facts
What the public records show
CMS Open Payments records show Khaja Asadullah, M.D. received $253.48 in general payments during 2025 across 13 reported records.
Lilly USA, LLC accounted for 19.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Myrbetriq by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 120 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $48.09 | 19.0% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $43.12 | 17.0% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $42.83 | 16.9% | 2 | 2025 |
| RECORDATI_RARE_DISEASES_INC. | Unresolved — no canonical attribution shown | $30.96 | 12.2% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $21.87 | 8.6% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $19.52 | 7.7% | 1 | 2025 |
| Acella Pharmaceuticals, LLC | Unresolved — no canonical attribution shown | $16.81 | 6.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.65 | 6.2% | 1 | 2025 |
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $14.63 | 5.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $253.48 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $48.09 | 3 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $43.12 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $42.83 | 2 | 2025 |
Source payment records
|
|||||
| ISTURISA Normalized: isturisa |
Drug | RECORDATI_RARE_DISEASES_INC. | $30.96 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $22.71 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $21.87 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $19.52 | 1 | 2025 |
Source payment records
|
|||||
| NP Thyroid 60 Normalized: np thyroid 60 |
Drug | Acella Pharmaceuticals, LLC | $16.81 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $15.65 | 1 | 2025 |
Source payment records
|
|||||
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $14.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
120 | 27 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1452 | 302 |
| Eliquis | Apixaban | 1076 | 140 |
| Amlodipine Besylate | Amlodipine Besylate | 929 | 208 |
| Gabapentin | Gabapentin | 762 | 130 |
| Furosemide | Furosemide | 674 | 152 |
| Pantoprazole Sodium | Pantoprazole Sodium | 648 | 142 |
| Levothyroxine Sodium | Levothyroxine Sodium | 586 | 126 |
| Potassium Chloride | Potassium Chloride | 506 | 103 |
| Metoprolol Tartrate | Metoprolol Tartrate | 492 | 102 |
| Losartan Potassium | Losartan Potassium | 462 | 105 |
| Lisinopril | Lisinopril | 459 | 97 |
| Clopidogrel | Clopidogrel Bisulfate | 445 | 80 |
| Tamsulosin Hcl | Tamsulosin Hcl | 438 | 75 |
| Metformin Hcl | Metformin Hcl | 417 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 391 | 91 |
| Omeprazole | Omeprazole | 334 | 76 |
| Donepezil Hcl | Donepezil Hcl | 331 | 57 |
| Carvedilol | Carvedilol | 317 | 80 |
| Levetiracetam | Levetiracetam | 310 | 44 |
| Hydralazine Hcl | Hydralazine Hcl | 300 | 63 |
| Memantine Hcl | Memantine Hcl | 285 | 50 |
| Famotidine | Famotidine | 279 | 68 |
| Allopurinol | Allopurinol | 264 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 259 | 68 |
| Trazodone Hcl | Trazodone Hcl | 247 | 51 |
| Sertraline Hcl | Sertraline Hcl | 226 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 210 | 74 |
| Mirtazapine | Mirtazapine | 203 | 49 |
| Warfarin Sodium | Warfarin Sodium | 182 | 17 |
| Simvastatin | Simvastatin | 180 | 37 |
| Nifedipine Er | Nifedipine | 179 | 28 |
| Baclofen | Baclofen | 178 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 172 | 32 |
| Spironolactone | Spironolactone | 157 | 43 |
| Prednisone | Prednisone | 150 | 57 |
| Januvia | Sitagliptin Phosphate | 148 | 16 |
| Latanoprost | Latanoprost | 146 | 40 |
| Montelukast Sodium | Montelukast Sodium | 146 | 36 |
| Divalproex Sodium | Divalproex Sodium | 140 | 25 |
| Midodrine Hcl | Midodrine Hcl | 129 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 126 | 33 |
| Risperidone | Risperidone | 126 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 24 |
| Jardiance | Empagliflozin | 120 | 27 |
| Entresto | Sacubitril/Valsartan | 116 | 17 |
| Sucralfate | Sucralfate | 115 | 20 |
| Alprazolam | Alprazolam | 113 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 110 | 32 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 108 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 99 | 28 |
| Xarelto | Rivaroxaban | 97 | 19 |
| Glipizide | Glipizide | 90 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 89 | 16 |
| Brimonidine Tartrate | Brimonidine Tartrate | 88 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 13 |
| Olanzapine | Olanzapine | 82 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 79 | 12 |
| Finasteride | Finasteride | 79 | 17 |
| Lactulose | Lactulose | 79 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 37 |
| Sevelamer Carbonate | Sevelamer Carbonate | 78 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 77 | 36 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 76 | 61 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 35 |
| Tramadol Hcl | Tramadol Hcl | 73 | 24 |
| Heparin Sodium | Heparin Sodium,porcine | 72 | 15 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 71 | 32 |
| Ezetimibe | Ezetimibe | 70 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 53 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 68 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 67 | 56 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 67 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 63 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 19 |
| Bumetanide | Bumetanide | 62 | 20 |
| Buspirone Hcl | Buspirone Hcl | 58 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 58 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Nystatin | Nystatin | 58 | 35 |
| Alendronate Sodium | Alendronate Sodium | 57 | 12 |
| Clonidine Hcl | Clonidine Hcl | 56 | 19 |
| Insulin Lispro | Insulin Lispro | 55 | 24 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 54 | 22 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 54 | suppressed |
| Tradjenta | Linagliptin | 52 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 50 | 42 |
| Brilinta | Ticagrelor | 49 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 48 | 18 |
| Methylprednisolone | Methylprednisolone | 48 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 12 |
| Topiramate | Topiramate | 48 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 46 | 25 |
| Naproxen | Naproxen | 46 | suppressed |
| Budesonide | Budesonide | 44 | 11 |
| Cephalexin | Cephalexin | 44 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | 12 |
| Celecoxib | Celecoxib | 42 | suppressed |
| Levemir | Insulin Detemir | 42 | suppressed |
| Linzess | Linaclotide | 42 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 42 | 11 |
| Ondansetron Odt | Ondansetron | 42 | 22 |
| Fluconazole | Fluconazole | 41 | 21 |
| Ibuprofen | Ibuprofen | 41 | 18 |
| Labetalol Hcl | Labetalol Hcl | 41 | suppressed |
| Calcium Acetate | Calcium Acetate | 40 | suppressed |
| Glipizide Er | Glipizide | 40 | suppressed |
| Lamotrigine | Lamotrigine | 40 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 40 | 14 |
| Chlorthalidone | Chlorthalidone | 39 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Torsemide | Torsemide | 39 | 14 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 38 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 37 | 14 |
| Jantoven | Warfarin Sodium | 34 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 33 | 15 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | 11 |
| Levofloxacin | Levofloxacin | 32 | 23 |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Lubiprostone | Lubiprostone | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 27 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | 11 |
| Xifaxan | Rifaximin | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Ertapenem | Ertapenem Sodium | 28 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 24 |
| Meloxicam | Meloxicam | 27 | 12 |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 21 |
| Dexamethasone | Dexamethasone | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | 12 |
| Glucagon Emergency Kit | Glucagon | 25 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 17 |
| Incruse Ellipta | Umeclidinium Bromide | 24 | suppressed |
| Admelog | Insulin Lispro | 23 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | 11 |
| Liothyronine Sodium | Liothyronine Sodium | 23 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 23 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 23 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Erythromycin | Erythromycin Base | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 22 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Daptomycin | Daptomycin | 21 | suppressed |
| Humalog | Insulin Lispro | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 21 | suppressed |
| Ampicillin-Sulbactam | Ampicillin Sod/Sulbactam Sod | 20 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Loperamide | Loperamide Hcl | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 20 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Letrozole | Letrozole | 18 | suppressed |
| Nyamyc | Nystatin | 18 | 11 |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 17 | suppressed |
| Insulin Aspart | Insulin Aspart | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 17 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 17 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Dulera | Mometasone/Formoterol | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Nateglinide | Nateglinide | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Vraylar | Cariprazine Hcl | 16 | suppressed |
| Acetazolamide | Acetazolamide | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 15 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 14 | suppressed |
| Brinzolamide | Brinzolamide | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Mesalamine Er | Mesalamine | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Dalfampridine Er | Dalfampridine | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 13 | 11 |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 12 | 12 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 12 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Meropenem | Meropenem | 11 | suppressed |
| Permethrin | Permethrin | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $253.48 · 13 records | Lilly USA, LLC | EVENITY, ISTURISA, Korlym, MOUNJARO, NEXLETOL, NP Thyroid 60, Ozempic, PROCLAIM, Rybelsus, Veozah | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error